Skip to contentC
Collegium Pharmaceutical, Inc
C
COLLCollegium Pharmaceutical, Inc Q1 2020 · 10-Q
Revenue$76.51M$76.51M+2.7% vs Q1 2019 Net Income$450.00K$450.00KN/M vs Q1 2019 EPS Diluted$0.01$0.01N/M vs Q1 2019 Gross Profit$38,987,000+53.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
Operating Cash Flow-$6,669,000N/M Free Cash Flowderived-$7,505,000N/M Margins · derivedGross margin51.0%+16.9 pt vs Q1 2019
Operating margin6.6%+20.0 pt vs Q1 2019
Net margin0.6%+13.6 pt vs Q1 2019
ended Mar 31, 2020 · filed May 7, 2020 · 37 d after period end